Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

Citing data from its Phase 2 MRI-based body composition sub-study, MOMENTUM, the Gaithersburg, Maryland-based biotech said ...